Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection
about
Mammalian Metallothionein-2A and Oxidative StressmiR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesisEffect of Inulin on Proteome Changes Induced by Pathogenic Lipopolysaccharide in Human ColonEpigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signallingModulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical ApplicationMetallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma)EOLA1 Inhibits Lipopolysaccharide-Induced Vascular Cell Adhesion Molecule-1 Expression by Association with MT2A in ECV304 Cells.Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation.Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population.KRAS NF-κB is involved in the development of zinc resistance and reduced curability in prostate cancer.NF-κB Signaling in Gastric Cancer.Glucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages.Metallothionein gene expression is altered in oral cancer and may predict metastasis and patient outcomes.Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population.The roles of metallothioneins in carcinogenesis
P2860
Q28070170-201D7481-8A9D-4903-B474-E5656AF6BFD8Q28384791-DB8E055D-172F-4433-9A9E-D20436AB4512Q28469369-10F1692B-1C9E-4BF0-9C24-F3C88C477C6DQ34998403-9CD69358-9C7F-4B7B-8838-B12789E98CB7Q35806779-EA34F3DA-9238-4B36-AEC4-414C2A5CA00EQ36292211-B114C8A8-AC19-4ACF-8FAF-CC4F1412BF20Q36352771-5D5DC6D9-52C4-48A1-9A62-6EFB6FE25AA4Q36529738-D2EB80A2-19A1-46E3-9D75-658C9A54EA7EQ36925753-4DFF8D69-C03C-44EA-8B52-A4230125F622Q37715508-1377F02A-4433-4C73-88FB-9D0B5AF5D2DEQ38985079-14ACE7FA-D5D9-44B4-8F99-C43E6DB00A72Q39204794-6DA85E4E-996C-4A61-8D05-1C9641DCD962Q47144286-081B7AA2-3F18-4238-847F-E31766D28856Q48230267-2168A275-1200-471F-BA1E-846F92AA63A9Q54201489-70584250-3024-46BE-9E65-0C6901D90100Q58713688-B1953ABA-3A55-4AD1-9284-97272FEE95F9
P2860
Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metallothionein 2A inhibits NF ...... ts following radical resection
@en
Metallothionein 2A inhibits NF ...... s following radical resection.
@nl
type
label
Metallothionein 2A inhibits NF ...... ts following radical resection
@en
Metallothionein 2A inhibits NF ...... s following radical resection.
@nl
prefLabel
Metallothionein 2A inhibits NF ...... ts following radical resection
@en
Metallothionein 2A inhibits NF ...... s following radical resection.
@nl
P2093
P2860
P356
P1476
Metallothionein 2A inhibits NF ...... ts following radical resection
@en
P2093
Jiantao Cui
Jiaqiang Huang
Youyong Lu
Yuanming Pan
P2860
P2888
P356
10.1186/1479-5876-11-173
P577
2013-07-19T00:00:00Z
P5875
P6179
1030205684